Alkem Laboratories receives EIR for Daman manufacturing facility

24 Jul 2018 Evaluate

Alkem Laboratories has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its manufacturing facility located at Amaliya, Daman, India which was inspected from March 19, 2018 to March 27, 2018.

In response to the Form 483 issued by the USFDA containing thirteen observations, the company had submitted a detailed corrective and preventive action (CAPA) plan to the regulator within the stipulated timeline. The inspection has now been closed by the USFDA.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.


Alkem Laboratories Share Price

5689.30 77.65 (1.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×